SPRY
NASDAQ · Biotechnology
Ars Pharmaceuticals Inc
$10.69
+0.41 (+3.99%)
Open$10.26
Previous Close$10.28
Day High$10.80
Day Low$10.26
52W High$18.90
52W Low$6.66
Volume—
Avg Volume1.31M
Market Cap958.28M
P/E Ratio—
EPS$-2.00
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+516.6% upside
Current
$10.69
$10.69
Target
$65.91
$65.91
$44.11
$65.91 avg
$67.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 84.03M | 357.40M | 350.63M |
| Net Income | -170,809,100 | 35.24M | 44.72M |
| Profit Margin | -203.3% | 9.9% | 12.8% |
| EBITDA | -178,141,144 | 65.64M | 71.27M |
| Free Cash Flow | — | 46.75M | 30.69M |
| Rev Growth | +299.7% | +16.3% | -1.3% |
| Debt/Equity | 0.84 | 0.42 | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |